IDO1 and neoplasm: Altogether, these data demonstrate that IDO1 catalytic inhibitors promote in the FTC-133 tumor cells an intrinsic side effect that enables the cells to migrate and proliferate faster than the control cells, resulting in a pro-tumorigenic effect.